These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36379903)

  • 1. Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant
    Lee MW; Kim GH
    Gut Liver; 2022 Nov; 16(6):807-808. PubMed ID: 36379903
    [No Abstract]   [Full Text] [Related]  

  • 2. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Zhang W; Chen Q; Liang X; Liu W; Xiao S; Graham DY; Lu H
    Gut; 2015 Nov; 64(11):1715-20. PubMed ID: 26338726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
    Xie Y; Zhu Z; Wang J; Zhang L; Zhang Z; Lu H; Zeng Z; Chen S; Liu D; Lv N;
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
    Tang D; Yuan L; Yue C; Cai T; Yao Y; Wang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):772-778. PubMed ID: 30124214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
    Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
    Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori treatment: Still a work in progress.
    Senatore FJ; Wilmot J; Birk JW
    Postgrad Med; 2016 Jan; 128(1):152-7. PubMed ID: 26490697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
    Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication in elderly patients: can we assume that a bismuth-based therapy is effective as in young people?
    Mladenova I
    Panminerva Med; 2022 Jun; 64(2):289. PubMed ID: 35815768
    [No Abstract]   [Full Text] [Related]  

  • 9. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
    Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In
    Flynn DJ; Feuerstein JD
    Ann Intern Med; 2023 May; 176(5):JC54. PubMed ID: 37126819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection].
    Campillo A; Ostiz M; Amorena E; Kutz M; La Iglesia M
    Med Clin (Barc); 2016 Sep; 147(5):199-201. PubMed ID: 27374029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
    World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quadruple therapy is more effective against H. pylori].
    Oberhofer E
    MMW Fortschr Med; 2016 May; 158(9):20. PubMed ID: 27155683
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis.
    Han Z; Li Y; Kong Q; Liu J; Wang J; Wan M; Lin M; Lin B; Zhang W; Ding Y; Wang S; Mu Y; Duan M; Zuo X; Li YQ
    Helicobacter; 2022 Dec; 27(6):e12930. PubMed ID: 36156332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
    Dehghani SM; Erjaee A; Imanieh MH; Haghighat M
    Dig Dis Sci; 2009 Aug; 54(8):1720-4. PubMed ID: 19005755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Chey WD; Leontiadis GI; Howden CW; Moss SF
    Am J Gastroenterol; 2017 Feb; 112(2):212-239. PubMed ID: 28071659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.
    Chang YW; Shin GY; Kim JW; Moon JC; Chang EJ; Oh CH; Jang JY
    Dig Dis Sci; 2022 Apr; 67(4):1222-1230. PubMed ID: 33755825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
    Zhou Y; Ye Z; Wang Y; Zhang Y; Tang Z; Yan W; Jiang Y; Huang Y
    Helicobacter; 2020 Apr; 25(2):e12679. PubMed ID: 31958193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.